The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of liquid biopsies for molecular profiling and monitoring in non-small cell lung cancer (NSCLC) patients.
 
Jordi Remon
No Relationships to Disclose
 
Jean-Charles Soria
Honoraria - AstraZeneca/MedImmune; Merus; MSD Oncology; Pfizer; Roche/Genentech; Symphony Evolution
 
Ludovic Lacroix
No Relationships to Disclose
 
Karen Howarth
Employment - Inivata
Research Funding - Inivata
 
Andrew Lawson
Employment - Inivata
Stock and Other Ownership Interests - Inivata
 
Sarah Smalley
Employment - Inivata
 
Davina Gale
Employment - Inivata
 
Vincent Plagnol
Employment - Inivata
Stock and Other Ownership Interests - Inivata
 
Emma Green
Employment - Inivata
Stock and Other Ownership Interests - Inivata
 
Nitzan Rosenfeld
Leadership - Inivata
Stock and Other Ownership Interests - Inivata
Consulting or Advisory Role - Inivata
Research Funding - AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - Inivata
 
Cecile Jovelet
No Relationships to Disclose
 
Chloe Pannet
No Relationships to Disclose
 
Benjamin Besse
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Inivata (Inst); Lilly (Inst); Onxeo (Inst); ose pharma (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Medarex; Novartis; Pfizer; Pierre Fabre; Roche